GO:0019372 lipoxygenase pathway: Lipid Mediator Biosynthesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019372 lipoxygenase pathway describes the enzymatic conversion of unsaturated fatty acids such as arachidonic acid or linolenic acid into hydroperoxide intermediates and downstream bioactive lipids.
• The pathway is initiated by lipoxygenase-catalyzed hydroperoxide formation and branches into leukotrienes, hepoxilins, jasmonates, and other oxylipins with distinct physiological roles.
• In mammals, the lipoxygenase pathway is central to immune regulation, epidermal barrier formation, and inflammatory mediator production.
• In plants, the same pathway produces jasmonates and green leaf volatiles that control development, defense, and wound responses.
• Dysregulation of lipoxygenase pathway genes is linked to cancer progression, hepatocyte lipid accumulation, and skin barrier disorders.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of lipoxygenase pathway gene function in disease contexts.
Description
The lipoxygenase pathway (GO:0019372) is a conserved metabolic route in which unsaturated fatty acids are oxygenated by lipoxygenase enzymes to form hydroperoxide intermediates that are subsequently converted into a diverse family of bioactive lipids. This pathway operates in plants, mammals, and other organisms, generating products that range from jasmonates and green leaf volatiles in plants to leukotrienes, hepoxilins, and other eicosanoids in mammals. Because these lipid mediators control inflammation, immunity, barrier function, and development, the pathway is a major focus in immunology, dermatology, plant biology, and cancer research. Understanding the lipoxygenase pathway at the molecular level requires identifying the enzymes, substrates, and regulatory nodes that determine which products are made and how they influence cell behavior. Recent studies have also implicated lipoxygenase pathway-related long non-coding RNAs and gene expression signatures in disease prognosis and metabolic regulation, expanding the pathway's relevance beyond classical lipid biochemistry.
lipoxygenase pathway At A Glance
| GO ID | GO:0019372 |
|---|---|
| GO term | lipoxygenase pathway |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Definition | The chemical reactions and pathways by which an unsaturated fatty acid (such as arachidonic acid or linolenic acid) is converted to other compounds, and in which the first step is hydroperoxide formation catalyzed by lipoxygenase. |
| Major function | Production of hydroperoxide intermediates and downstream bioactive lipids from unsaturated fatty acids |
| Organisms | Plants, mammals, and other eukaryotes |
| Key substrates | Arachidonic acid, linolenic acid, and other polyunsaturated fatty acids |
| Representative products | Leukotrienes, hepoxilins, jasmonates, green leaf volatiles, and other oxylipins |
What Is GO:0019372?
According to the Gene Ontology, GO:0019372 lipoxygenase pathway is defined as the chemical reactions and pathways by which an unsaturated fatty acid such as arachidonic acid or linolenic acid is converted to other compounds, and in which the first step is hydroperoxide formation catalyzed by lipoxygenase. In other words, it is a metabolic process that begins with lipoxygenase-mediated oxygenation of a polyunsaturated fatty acid to a hydroperoxide, followed by downstream enzymatic or non-enzymatic transformations that yield various lipid mediators.
Why Is lipoxygenase pathway Important in Cell Biology?
The lipoxygenase pathway is important because it generates lipid mediators that regulate inflammation, immunity, epidermal barrier function, plant development, and defense responses. In mammals, leukotrienes and hepoxilins produced through this pathway influence immune cell recruitment, vascular tone, and skin permeability, making the pathway a therapeutic target in inflammatory and dermatological diseases. In plants, lipoxygenase-derived jasmonates and volatile aldehydes coordinate wound responses, pathogen defense, and reproductive development. Moreover, dysregulated lipoxygenase pathway activity has been associated with cancer progression and metabolic disorders such as hepatic lipid accumulation, highlighting its broad biomedical significance.
• Generates leukotrienes and other eicosanoids that drive inflammatory and allergic responses.
• Supports epidermal barrier formation through the hepoxilin branch of the pathway.
• Produces jasmonates and green leaf volatiles that mediate plant defense and development.
• Contributes to xenobiotic metabolism via non-specific oxidative reactions.
• Lipoxygenase pathway-related lncRNAs have been used to build prognostic signatures in breast cancer.
• Atorvastatin modulates lipoxygenase pathway-related gene expression in hepatocyte lipid accumulation models.
• Provides druggable targets for anti-inflammatory and anti-leukotriene therapies.
• Serves as a model system for studying enzyme-catalyzed lipid peroxidation and its regulation.
• Links dietary fatty acid intake to cellular signaling and gene expression.
• Enables cross-kingdom comparison of oxylipin signaling mechanisms.
What Happens During lipoxygenase pathway?
Initiation by lipoxygenase-mediated hydroperoxide formation
In simple terms: The pathway starts when a lipoxygenase enzyme adds oxygen to an unsaturated fatty acid, creating a hydroperoxide.
The first and defining step of GO:0019372 is the lipoxygenase-catalyzed conversion of an unsaturated fatty acid such as arachidonic acid or linolenic acid into a hydroperoxide intermediate. Lipoxygenases are non-heme iron-containing enzymes that abstract a hydrogen atom from a bis-allylic methylene and insert molecular oxygen, yielding a fatty acid hydroperoxide with positional and stereochemical specificity. This initial oxygenation reaction commits the substrate to the lipoxygenase pathway and determines the downstream product profile.
Branching into leukotriene and hepoxilin synthesis in mammals
In simple terms: In mammals, the hydroperoxide can be converted into leukotrienes and hepoxilins, which are signaling lipids.
In mammalian cells, the hydroperoxide generated by 5-lipoxygenase is further processed to leukotriene A4, which can be converted to leukotriene B4 or cysteinyl leukotrienes that act as potent immune mediators. Alternatively, 12-lipoxygenase and related enzymes can produce hepoxilins, which contribute to epidermal barrier function and cutaneous homeostasis. These branches illustrate how a single initiating reaction can yield multiple bioactive products with distinct physiological roles.
Jasmonate and volatile production in plants
In simple terms: In plants, the same pathway makes jasmonates and volatile compounds that help the plant respond to stress.
Plant lipoxygenases initiate the pathway by oxygenating linolenic acid to 13-hydroperoxy linolenic acid, which is subsequently converted through the octadecanoid pathway to jasmonic acid and its derivatives. These jasmonates regulate defense gene expression, wound responses, and reproductive development. In parallel, hydroperoxide lyase can divert intermediates to green leaf volatiles and other aldehydes that serve as defense signals and aroma compounds.
Non-specific oxidative metabolism of xenobiotics
In simple terms: Lipoxygenase can also oxidize foreign compounds, acting as a non-specific metabolic route.
Beyond physiological fatty acid substrates, lipoxygenase activity has been implicated in the non-specific oxidative metabolism of xenobiotics, expanding the pathway's functional repertoire beyond endogenous lipid mediator synthesis. This co-oxidation capacity suggests that lipoxygenase pathway enzymes can influence the fate of drugs and environmental chemicals, although the physiological significance requires further study.
Regulation of pathway flux and product diversity
In simple terms: The pathway is controlled by which enzymes are present and how active they are, which determines the final products.
The flux through GO:0019372 is regulated by the expression and activity of specific lipoxygenase isoforms, substrate availability, and downstream converting enzymes. In mammals, calcium and ATP influence 5-lipoxygenase localization and activation, while in plants, jasmonate biosynthesis is feedback-regulated by the products themselves. Additionally, statins such as atorvastatin can modulate lipoxygenase pathway-related gene expression in hepatocytes, indicating pharmacological control of pathway activity.
Key Genes Involved in GO:0019372 lipoxygenase pathway
The following genes and proteins are central to the lipoxygenase pathway (GO:0019372) and are frequently studied in plant, mammalian, and disease-focused research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALOX5 | 5-lipoxygenase; initiates leukotriene synthesis from arachidonic acid | Target in asthma, inflammation, and leukotriene-modifying drugs |
| ALOX5AP | 5-lipoxygenase activating protein; required for 5-lipoxygenase activity | Genetic variants linked to inflammatory diseases |
| ALOX12 | 12-lipoxygenase; produces 12-HETE and hepoxilins | Studied in epidermal barrier and cancer |
| ALOX15 | 15-lipoxygenase; generates 15-HETE and related oxylipins | Implicated in inflammation and cancer |
| ALOX12B | 12R-lipoxygenase; involved in epidermal ceramide processing | Mutations cause ichthyosis and barrier defects |
| ALOXE3 | Epidermis-type lipoxygenase 3; hepoxilin pathway enzyme | Essential for skin permeability barrier |
| LOX1 | Plant lipoxygenase; initiates octadecanoid pathway | Model for jasmonate biosynthesis |
| LOX2 | Plant lipoxygenase isoform; contributes to wound-induced jasmonate | Studied in plant defense signaling |
| AOS | Allene oxide synthase; converts hydroperoxide to jasmonate precursor | Key branch point in plant oxylipin pathway |
| HPL | Hydroperoxide lyase; produces green leaf volatiles | Defense and aroma compound research |
| LTC4S | Leukotriene C4 synthase; conjugates LTA4 with glutathione | Target in allergic inflammation |
| LTA4H | Leukotriene A4 hydrolase; converts LTA4 to LTB4 | Drug target in inflammatory disease |
| PTGS2 | Cyclooxygenase-2; cross-talks with lipoxygenase pathway | Context for eicosanoid balance |
| PLA2G4A | Cytosolic phospholipase A2; releases arachidonic acid | Upstream regulator of substrate supply |
| NCOA4 | Nuclear receptor coactivator 4; may influence lipid metabolism | Potential link to lipoxygenase pathway lncRNA signatures |
| STAT3 | Transcription factor; modulates inflammatory gene expression | Cross-regulates lipoxygenase pathway genes |
| PPARG | Peroxisome proliferator-activated receptor gamma; lipid signaling | Interacts with oxylipin signaling |
How Is lipoxygenase pathway Regulated?
The lipoxygenase pathway is regulated at multiple levels, including substrate availability, enzyme expression, and post-translational activation. In mammals, cytosolic phospholipase A2 releases arachidonic acid from membrane phospholipids, providing substrate for 5-lipoxygenase, which requires the 5-lipoxygenase activating protein (FLAP) and calcium for activity. In plants, jasmonate biosynthesis is controlled by the expression of LOX, AOS, and other pathway genes in response to wounding and pathogen attack. Pharmacological agents such as atorvastatin can alter the expression of lipoxygenase pathway-related genes in hepatocytes, demonstrating that the pathway is responsive to metabolic and drug signals. Additionally, long non-coding RNAs may modulate pathway-related gene expression in cancer, as suggested by prognostic signatures derived from lipoxygenase pathway-related lncRNAs.
lipoxygenase pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALOX5 | Asthma and allergic inflammation | Knockout mouse or human airway epithelial cells |
| ALOX12B | Autosomal recessive congenital ichthyosis | Keratinocyte knockout or point-mutation models |
| ALOXE3 | Epidermal barrier defect | 3D skin equivalents with CRISPR knockout |
| ALOX5AP | Inflammatory disease susceptibility | Overexpression or knockout in immune cells |
| Lipoxygenase pathway lncRNAs | Breast cancer prognosis | Knockdown or overexpression in breast cancer cell lines |
Lipoxygenase pathway in inflammatory and allergic diseases
Leukotrienes produced through the 5-lipoxygenase branch of GO:0019372 are potent mediators of inflammation, bronchoconstriction, and mucus secretion, making the pathway a validated target in asthma and allergic rhinitis. Drugs that inhibit 5-lipoxygenase or leukotriene receptors are used clinically, underscoring the pathway's therapeutic importance. Dysregulated leukotriene synthesis also contributes to atherosclerosis and other chronic inflammatory conditions.
Epidermal barrier disorders and hepoxilin pathway
The hepoxilin branch of the lipoxygenase pathway, involving ALOX12B and ALOXE3, is critical for skin permeability barrier formation. Mutations in these genes cause autosomal recessive congenital ichthyosis, a group of severe skin disorders characterized by defective barrier function. This highlights the non-redundant role of specific lipoxygenase pathway enzymes in human epidermal biology.
Cancer prognosis and lipoxygenase pathway-related lncRNAs
A risk prediction model based on lipoxygenase pathway-related long non-coding RNAs has been developed for breast cancer prognosis, indicating that pathway-associated non-coding RNAs can serve as biomarkers. This suggests that the lipoxygenase pathway influences tumor biology beyond enzymatic lipid mediator production, potentially through regulatory RNA networks.
Metabolic liver disease and statin modulation
In an in vitro model of lipid accumulation in hepatocytes, atorvastatin treatment altered the expression of lipoxygenase pathway-related genes, linking the pathway to hepatic lipid metabolism and potential non-alcoholic fatty liver disease mechanisms. This finding suggests that lipoxygenase pathway activity may be modifiable by statins and could contribute to liver steatosis.
From lipoxygenase pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ALOX5 reduce leukotriene production? | ALOX5 knockout cell line or mouse |
| Does a point mutation in ALOX12B impair epidermal barrier? | CRISPR point-mutation knock-in in keratinocytes |
| Can hepoxilin synthesis be restored by ALOXE3 knock-in? | Knock-in of wild-type ALOXE3 in deficient cells |
| Does overexpression of a lipoxygenase pathway lncRNA alter cancer cell proliferation? | Overexpression cell model in breast cancer lines |
| How does atorvastatin affect lipoxygenase pathway gene expression? | Hepatocyte lipid accumulation model with statin treatment |
| What is the role of plant LOX in jasmonate production? | Arabidopsis LOX knockout or overexpression lines |
How to Study the lipoxygenase pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS lipidomics | Hydroperoxides, leukotrienes, hepoxilins, jasmonates | Quantifying pathway products in cells and tissues |
| RNA-seq | Expression of lipoxygenase pathway genes and lncRNAs | Prognostic signatures and pathway regulation |
| Lipoxygenase activity assay | Enzymatic hydroperoxide formation | Functional validation of LOX enzymes |
| CRISPR knockout screening | Genes required for pathway activity or disease phenotypes | Discovery of pathway modifiers |
| Western blotting | Protein levels of ALOX isoforms | Confirming knockout or overexpression |
| Immunofluorescence | Subcellular localization of lipoxygenases | Studying enzyme trafficking |
| qRT-PCR | mRNA levels of pathway genes | Statin or wounding response studies |
| Plant jasmonate profiling | Jasmonic acid and derivatives | Plant defense and development research |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics is essential for quantifying hydroperoxide intermediates and downstream products of the lipoxygenase pathway, such as leukotrienes, hepoxilins, and jasmonates. Targeted methods can measure specific oxylipins, while untargeted approaches reveal global changes in lipid mediator profiles.
Transcriptomics and RNA sequencing
RNA sequencing can assess the expression of lipoxygenase pathway genes and related long non-coding RNAs under different conditions, as demonstrated in breast cancer prognostic signature studies. In plants, transcriptomics reveals coordinated induction of LOX, AOS, and other pathway genes after wounding or pathogen challenge.
Enzyme activity assays
Lipoxygenase activity can be measured spectrophotometrically by monitoring hydroperoxide formation at 234 nm or by using oxygen consumption assays. These assays are used to confirm the functional impact of genetic perturbations in the pathway.
CRISPR-based genetic screens
Pooled CRISPR knockout screens can identify genes that regulate lipoxygenase pathway activity or mediate its downstream effects, enabling unbiased discovery of pathway components and modifiers. Such screens are particularly useful for linking pathway genes to disease phenotypes.
How CRISPR Can Be Used to Study GO:0019372 lipoxygenase pathway
Knockout
CRISPR knockout of lipoxygenase pathway genes such as ALOX5, ALOX12B, or plant LOX enables loss-of-function studies to determine their contribution to lipid mediator production and disease phenotypes. Knockout cell lines and animal models are valuable for validating drug targets and understanding pathway redundancy.
Point Mutation
Point mutations in lipoxygenase genes can mimic naturally occurring variants or catalytically dead enzymes, allowing precise dissection of enzymatic activity versus structural roles. For example, point mutations in ALOX12B associated with ichthyosis can be introduced into keratinocytes to study barrier defects.
Knock-in
Knock-in of tagged or wild-type lipoxygenase genes can restore function in deficient cells or enable tracking of enzyme localization and interactions. This approach is useful for studying hepoxilin pathway restoration and for creating reporter lines.
Overexpression
Overexpression of lipoxygenase pathway genes or related lncRNAs can model gain-of-function states observed in cancer and inflammatory diseases. Overexpression models help identify downstream signaling changes and potential therapeutic vulnerabilities.
How EDITGENE Supports lipoxygenase pathway Research
Researchers studying lipoxygenase pathway-related genes often need to determine whether a candidate gene is causally involved in lipid mediator production, disease progression, or drug response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for lipoxygenase pathway research.
Frequently Asked Questions About lipoxygenase pathway
What is the lipoxygenase pathway (GO:0019372)?
The lipoxygenase pathway is a biological process in which unsaturated fatty acids such as arachidonic acid or linolenic acid are converted to other compounds, starting with lipoxygenase-catalyzed hydroperoxide formation.
What genes are involved in the lipoxygenase pathway?
Key genes include ALOX5, ALOX12, ALOX15, ALOX12B, ALOXE3, LTA4H, LTC4S in mammals, and LOX, AOS, HPL in plants.
What diseases are associated with the lipoxygenase pathway?
The pathway is linked to asthma, allergic inflammation, congenital ichthyosis, breast cancer prognosis, and hepatic lipid accumulation.
How is the lipoxygenase pathway regulated?
It is regulated by substrate availability, enzyme expression, calcium signaling, and pharmacological agents such as atorvastatin.
What are the products of the lipoxygenase pathway?
Products include leukotrienes, hepoxilins, jasmonates, green leaf volatiles, and various oxylipins.
How can I study the lipoxygenase pathway using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of pathway genes in disease-relevant cells.
What is the role of ALOX5 in the lipoxygenase pathway?
ALOX5 encodes 5-lipoxygenase, which initiates leukotriene synthesis from arachidonic acid and is a drug target in inflammatory diseases.
What is the hepoxilin pathway?
The hepoxilin pathway is a branch of the lipoxygenase pathway involving ALOX12B and ALOXE3 that is essential for epidermal barrier formation.
Can lipoxygenase pathway lncRNAs be used as cancer biomarkers?
Yes, a risk prediction model based on lipoxygenase pathway-related lncRNAs has been developed for breast cancer prognosis.
What model systems are used to study the lipoxygenase pathway?
Common models include mammalian cell lines, keratinocytes, hepatocytes, knockout mice, and plant models such as Arabidopsis.
Conclusion
The lipoxygenase pathway (GO:0019372) is a fundamental metabolic process that converts unsaturated fatty acids into a wide array of bioactive lipids with critical roles in immunity, barrier function, plant defense, and disease. Its dysregulation contributes to inflammatory diseases, skin disorders, cancer, and metabolic conditions, making it a rich area for therapeutic targeting and biomarker discovery. CRISPR-based models and advanced omics technologies now enable precise interrogation of pathway genes, offering new opportunities to translate lipoxygenase biology into clinical and agricultural applications.
References
- 1. Feussner I et al.. 2002. The lipoxygenase pathway.. Annu Rev Plant Biol 53:275-97 PMID: 12221977
- 2. Abe M et al.. 2004. [Leukotriene-lipoxygenase pathway and drug discovery].. Nihon Yakurigaku Zasshi 124(6):415-25 PMID: 15572846
- 3. Muñoz-Garcia A et al.. 2014. The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier.. Biochim Biophys Acta 1841(3):401-8 PMID: 24021977
- 4. Fu X et al.. 2025. Developing the risk prediction model (ProlncSig) from lipoxygenase pathway-related lncRNAs for prognosis prediction in breast cancer.. RNA Biol 22(1):1-19 PMID: 40820368
- 5. Akhilender Naidu KA et al.. 1994. Lipoxygenase: a non-specific oxidative pathway for xenobiotic metabolism.. Prostaglandins Leukot Essent Fatty Acids 50(4):155-9 PMID: 8022848
- 6. Parker CW. 1987. Lipid mediators produced through the lipoxygenase pathway.. Annu Rev Immunol 5:65-84 PMID: 3036183
- 7. Gardner HW. 1991. Recent investigations into the lipoxygenase pathway of plants.. Biochim Biophys Acta 1084(3):221-39 PMID: 1909580
- 8. Golfetto Miskiewicz IC et al.. 2023. Effect of atorvastatin on lipoxygenase pathway-related gene expression in an in vitro model of lipid accumulation in hepatocytes.. FEBS Open Bio 13(4):606-616 PMID: 36637998
